Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy

被引：22
|
作者：
Mejstríková, E
Kalina, T
Trka, J
Stary, J
Hrusák, O
机构：
[1] Charles Univ Prague, Sch Med 2, Dept Immunol, Prague 15006 5, Czech Republic
[2] Charles Univ Prague, Sch Med 2, CLIP, Prague, Czech Republic
[3] Charles Univ Prague, Sch Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic
来源：
LEUKEMIA | 2005年 / 19卷 / 06期
关键词：
D O I：
10.1038/sj.leu.2403737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1092 / 1094
页数：3
相关论文
共 50 条
  • [1] Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy
    E Mejstříková
    T Kalina
    J Trka
    J Starý
    O Hrušák
    Leukemia, 2005, 19 : 1092 - 1094
  • [2] Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia
    Laing, Alison A.
    Harrison, Christine J.
    Gibson, Brenda E. S.
    Keeshan, Karen
    EXPERIMENTAL HEMATOLOGY, 2017, 54 : 40 - 50
  • [3] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Michele Stanchina
    Alessandro Pastore
    Sean Devlin
    Christopher Famulare
    Eytan Stein
    Justin Taylor
    Journal of Hematology & Oncology, 12
  • [4] CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Stanchina, Michele
    Pastore, Alessandro
    Devlin, Sean
    Famulare, Christopher
    Stein, Eytan
    Taylor, Justin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [5] Base Edited HSPCs Are Shielded from Targeted CD33 Therapy but Preserve CD33 Expression
    Beerlage, Astrid
    Garaude, Simon
    Lepore, Rosalba
    Burgold, Thomas
    Camus, Anna
    Testut, Mathilde
    Urlinger, Stefanie
    Jeker, Lukas T.
    BLOOD, 2023, 142
  • [6] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Jurcic, Joseph G.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 65 - 73
  • [7] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Joseph G. Jurcic
    Current Hematologic Malignancy Reports, 2012, 7 : 65 - 73
  • [8] CD33 BiTE: From Molecule to Therapy
    Subklewe, Marion
    ANNALS OF HEMATOLOGY, 2019, 98 : S69 - S70
  • [9] ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR THERAPY FOR ACUTE MYELOID LEUKEMIA
    O'Hear, Carol
    Heiber, Joshua
    Geiger, Terrence
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S1 - S1
  • [10] Ab therapy of AML: native anti-CD33 Ab and drug conjugates
    Jurcic, J. G.
    CYTOTHERAPY, 2008, 10 (01) : 7 - 12
12345